RARE - Ultragenyx announces proposed public offering of common stock
2023-10-17 16:07:13 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx: Market Expectations Revised Lower, Awaiting Clinical Trial Catalysts (Rating Downgrade)
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical
- Historical earnings data for Ultragenyx Pharmaceutical
For further details see:
Ultragenyx announces proposed public offering of common stock